DPUK collaboration identifies possible new target for drug repurposing in dementia
Jodi Watt, a Postdoctoral Researcher at the University of Glasgow, is part of a team involving researchers at the University of Glasgow, Cardiff University, University of Cambridge, and St George’s…
Read the full articleYou might also wanna read
Network-driven discovery of repurposable drugs targeting hallmarks of aging
Network-driven discovery of repurposable drugs targeting hallmarks of aging
Croatian researchers thrust into limelight as their 1990s’ peptide discovery goes mainstream in the US
Trump administration hopes to approve peptides popular with MAHA wellbeing advocates. How are the researchers at the centre of this coping w
Study to Evaluate the Safety and Efficacy of Ublituximab in Participants With Schizophrenia
Conditions : Schizophrenia Interventions : Drug: Ublituximab Sponsors : TG Therapeutics, Inc. Not yet recruiting
New probe could help trace Alzheimer's-linked lipids one cell at a time
Cells sitting side by side in the same tissues are not identical. Each cell carries its own subtly different chemical signature—a hidden ind
The participative arts for people living with a dementia: a critical review
In the last decade, interest has increased in the role of the participative arts for people who are living with a dementia. The flourishing
Northwestern study identifies schizophrenia biomarker and potential drug candidate for cognitive symptoms
A new Northwestern University study in humans and mice has discovered a novel biomarker of schizophrenia that could also serve as a new drug
news.northwestern.edu·3mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.